Biotech

All Articles

2 cancer cells biotechs merge, making international impact

.OncoC4 is taking AcroImmune-- as well as its in-house professional production functionalities-- und...

Amgen reports first stage 3 gain for $400M eczema medicine

.Amgen has actually shared (PDF) the 1st phase 3 information on its $400 thousand dermatitis drug, l...

Biogen, UCB file stage 3 lupus gain after stopping working earlier test

.Biogen and UCB's bank on advancing into period 3 astride an unsuccessful study tries to have paid o...

Aptadir wishes brand-new RNA inhibitors can reverse challenging cancers

.Italian biotech Aptadir Therapeutics has launched along with the assurance that its own pipe of pre...

Wave surfs DMD success to regulators' doors, sending out stockpile

.Wave Life Sciences has actually fulfilled its own objective in a Duchenne muscle dystrophy (DMD) re...

Sanofi picks new CSO coming from in-stealth biotech

.After a few years in biotech, Mike Quigley, Ph.D., is coming back to the pharma layer, using up the...

Achilles drops tissue therapy program, supports for layoffs after skipping 'commercial stability' goals

.Achilles Therapies has actually shreded its approach. The British biotech is stopping work on its o...

Aligos trumpets phase 2 MASH succeed, slashing liver fat as much as 46%

.Aligos Therapies is actually heralding a midstage gain in metabolic-dysfunction associated steatohe...

Basilea ratings $268M BARDA backing for antifungals, prescription antibiotics

.Basilea Pharmaceutica's job establishing brand new antifungals has received a substantial improveme...

Capricor sells Europe civil liberties to late-stage DMD therapy for $35M

.Possessing actually gathered up the U.S. rights to Capricor Therapeutics' late-stage Duchenne muscl...